Literature DB >> 26518581

Neonatal Ureaplasma urealyticum colonization increases pulmonary and cerebral morbidity despite treatment with macrolide antibiotics.

Bernhard Resch1,2, C Gutmann3, F Reiterer4, J Luxner5, B Urlesberger4.   

Abstract

OBJECTIVE: To evaluate the influence of Ureaplasma urealyticum (UU) colonization on neonatal pulmonary and cerebral morbidity.
METHODS: Single-center case-control study including all preterm infants with positive UU tracheal colonization between 1990 and 2012. Cases were matched with controls by birth year, gestational age, birth weight, and sex. All cases had received macrolide antibiotics for UU infection starting at the time of first positive culture results from tracheal aspirates. Main outcome parameters included presence and severity of hyaline membrane disease (IRDS), duration of ventilation, bronchopulmonary dysplasia at 36 postmenstrual age and neurological morbidities (seizures, intra-/periventricular hemorrhages-I/PVH, periventricular leukomalacia-PVL).
RESULTS: Of 74 cases identified 8 died and 4 had to be excluded; thus, 62 preterm infants were compared to 62 matched controls. UU was significantly associated with IRDS (79 vs. 61 %, p = 0.015), BPD (24 vs. 6 %, p = 0.003), seizures (23 vs. 5 %, p = 0.002) and I/PVH (45 vs. 24 %, p = 0.028). Cases had longer duration of mechanical ventilation and total duration of invasive and non-invasive ventilation (median 11 vs. 6 days p = 0.006 and 25 vs. 16.5 days p = 0.019, respectively).
CONCLUSION: UU was found to be significantly associated with pulmonary short- and long-term morbidity and mild cerebral impairment despite treatment with macrolide antibiotics.

Entities:  

Keywords:  Bronchopulmonary dysplasia; Erythromycin; Intraventricular hemorrhage; Respiratory distress syndrome; Ureaplasma urealyticum

Mesh:

Substances:

Year:  2015        PMID: 26518581     DOI: 10.1007/s15010-015-0858-7

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  30 in total

1.  Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants.

Authors:  G H Cassell; K B Waites; D T Crouse; P T Rudd; K C Canupp; S Stagno; G R Cutter
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

2.  Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum-positive preterm infants.

Authors:  Ramazan Ozdemir; Omer Erdeve; Evrim Alyamac Dizdar; Serife Suna Oguz; Nurdan Uras; Sibel Saygan; Erdem Karabulut; Ugur Dilmen
Journal:  Pediatrics       Date:  2011-11-28       Impact factor: 7.124

3.  Maternal genital colonization with Ureaplasma urealyticum promotes preterm delivery: association of the respiratory colonization of premature infants with chronic lung disease and increased mortality.

Authors:  Dimitris A Kafetzis; Chrysanthi L Skevaki; Vassiliki Skouteri; Stavroula Gavrili; Katerina Peppa; Christos Kostalos; Vassiliki Petrochilou; Stellios Michalas
Journal:  Clin Infect Dis       Date:  2004-09-27       Impact factor: 9.079

4.  Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women.

Authors:  Mehmet Refik Bayraktar; Ibrahim Halil Ozerol; Nilay Gucluer; Onder Celik
Journal:  Int J Infect Dis       Date:  2009-06-09       Impact factor: 3.623

5.  Appropriate antibiotic therapy improves Ureaplasma sepsis outcome in the neonatal mouse.

Authors:  Leonard E Weisman; Angela H Leeming; Lingkun Kong
Journal:  Pediatr Res       Date:  2012-08-20       Impact factor: 3.756

6.  Incidence of invasive ureaplasma in VLBW infants: relationship to severe intraventricular hemorrhage.

Authors:  R M Viscardi; N Hashmi; G W Gross; C-C J Sun; A Rodriguez; K D Fairchild
Journal:  J Perinatol       Date:  2008-07-03       Impact factor: 2.521

7.  Certain type of chronic lung disease of newborns is associated with Ureaplasma urealyticum infection in utero.

Authors:  Yoko Honma; Yukari Yada; Naoto Takahashi; Mariko Y Momoi; Yoshikazu Nakamura
Journal:  Pediatr Int       Date:  2007-08       Impact factor: 1.524

Review 8.  Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum.

Authors:  C G Mabanta; G S Pryhuber; G A Weinberg; D L Phelps
Journal:  Cochrane Database Syst Rev       Date:  2003

9.  Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.

Authors:  H Renaudin; C Bébéar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

10.  Molecular evidence of Ureaplasma urealyticum and Ureaplasma parvum colonization in preterm infants during respiratory distress syndrome.

Authors:  Rosario Cultrera; Silva Seraceni; Rossella Germani; Carlo Contini
Journal:  BMC Infect Dis       Date:  2006-11-21       Impact factor: 3.090

View more
  3 in total

1.  Bronchopulmonary dysplasia in very preterm infants: Outcome up to preschool age, in a single center of Austria.

Authors:  Friedrich Reiterer; Anna Scheuchenegger; Bernhard Resch; Ute Maurer-Fellbaum; Alexander Avian; Berndt Urlesberger
Journal:  Pediatr Int       Date:  2019-04-17       Impact factor: 1.524

2.  A novel bioreactor for the stable growth of Ureaplasma parvum and Ureaplasma urealyticum.

Authors:  Derek Fleming; Melissa Karau; Robin Patel
Journal:  J Microbiol Methods       Date:  2020-12-30       Impact factor: 2.363

3.  Analysis of the Clinical Features of Intrauterine Ureaplasma urealyticum Infection in Preterm Infants: A Case-Control Study.

Authors:  Tong Sun; Jianhua Fu
Journal:  Front Pediatr       Date:  2021-12-09       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.